These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6426612)

  • 1. Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.
    Baker JR; Johnson RN; Scott DJ
    Br Med J (Clin Res Ed); 1984 May; 288(6429):1484-6. PubMed ID: 6426612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of fasting blood glucose and serum fructosamine as a measure of diabetic control in non-insulin-dependent diabetes mellitus.
    Kruseman AC; Mercelina L; Degenaar CP
    Horm Metab Res Suppl; 1992; 26():59-62. PubMed ID: 1490693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levels of fasting blood glucose and serum fructosamine for monitoring of glucose control in patients with non-insulin-dependent diabetes mellitus].
    Mercelina LF; Degenaar CP; Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 1989 Sep; 133(38):1887-90. PubMed ID: 2797305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus.
    Baker JR; Metcalf PA; Holdaway IM; Johnson RN
    Br Med J (Clin Res Ed); 1985 Feb; 290(6465):352-5. PubMed ID: 3917816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients.
    MacRury SM; Kilpatrick ES; Paterson KR; Dominiczak MH
    Clin Chim Acta; 1991 May; 199(1):51-8. PubMed ID: 1934502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fructosamine in patients with diabetes mellitus.
    Baker J; Reid I; Holdaway I
    N Z Med J; 1985 Jul; 98(782):532-5. PubMed ID: 3861965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructosamine: an alternative assessment of past glycaemic control in developing countries.
    Islam N; Akhter J; Kayani N; Khan MA
    J Pak Med Assoc; 1993 Nov; 43(11):238-40. PubMed ID: 8114262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].
    Hay U; Sedlmayer A; Müller MM; Dorda W; Schernthaner G
    Klin Wochenschr; 1989 Apr; 67(7):379-85. PubMed ID: 2747138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of plasma fructosamine in the assessment of diabetic control.
    Saeed BO; elWali NM; Atabani GS; Elmahdi EM; Mukhtar E
    Trop Geogr Med; 1991; 43(1-2):51-4. PubMed ID: 1750129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical usefulness of serum fructosamine and HbAlc in patients with NIDDM.
    Lim SY; Jhoo YM; Lee SS; Lee MH; Chung ES; Lee SJ
    Korean J Intern Med; 1989 Jul; 4(2):155-9. PubMed ID: 2486845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level.
    Tahara Y; Shima K
    Diabetes Care; 1995 Apr; 18(4):440-7. PubMed ID: 7497851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
    Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of fructosamine, glycosylated hemoglobin and glucose in patients with type II diabetes].
    Tvorogova MG; Zaĭtseva TM; Aronskaia EE; Kozlov SG; Sharipova GKh; Titov VN
    Klin Lab Diagn; 1995; (1):10-2. PubMed ID: 7757352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of HbA1c, fructosamine and the main metabolic parameters in a non-insulin-dependent diabetic population].
    Magnati G; Arsenio L; Baroni MC; Bodria P; Bossi S; Delsignore R; Ippolito L; Mineo F; Strata A
    G Clin Med; 1990 Jan; 71(1):25-30. PubMed ID: 2365166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of fructosamine determination in short-term monitoring of metabolic control in children with insulin-dependent diabetes mellitus at onset].
    De Campo C; Monciotti C; Grossi F; Bertotti A; Pocecco M
    Pediatr Med Chir; 1987; 9(5):583-4. PubMed ID: 3327054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of diabetes mellitus and an assessment of methods of detection among a community of elderly Chinese in Hong Kong.
    Woo J; Swaminathan R; Cockram C; Pang CP; Mak YT; Au SY; Vallance-Owen J
    Diabetologia; 1987 Nov; 30(11):863-8. PubMed ID: 3446553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Routine control of type 2 diabetes. Are glycosylated hemoglobin and fructosamine measurements necessary?].
    Tryggeseth A
    Tidsskr Nor Laegeforen; 1990 Aug; 110(19):2539-40. PubMed ID: 2219017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.